Zymeworks Inc.: Leerink Partners assumes coverage with outperform rating; price target $60
ZYME•Leerink Partners assumed coverage of Zymeworks Inc. with an outperform rating and a $60 price target.
Related News
Maximus declares quarterly cash dividend of $0.33 per share
MMS•
Church & Dwight target price cut to $105 from $110
CHD•
Coca-Cola: Wells Fargo cuts target price to $90 from $95
KO•
BP has no plans to shy away from the Middle East, CEO says
BP•
Sea CCO and GC Wang Yanjun disposes of $190,241 in common shares
SE•